Celltrion | 068270 - 销售收入

金融业

KRW

KRW 759.44B

现金及等价物

KRW 49.87B

KRW 107.42B

KRW 470.6B

KRW 283.62B

KRW 161.31B

股息收益率

0.41

KRW 12.08B

KRW 17.79B

1.07K

EPS每股收益

KRW 1.58K

股本和储备

KRW 435.96B

KRW 46.98B

债务利息支出

KRW 19B

KRW 621.35M

KRW 412.27B

KRW 37588.31B

KRW 8.88B

KRW 140.68B

KRW 13.72B

普通股股本

KRW 218.61M

67.83

KRW 10.5B

KRW 1150B

销售和管理费用

KRW 12.71B

KRW 122.94B

贸易债权人

KRW 78.68B

应收帐款人

KRW 2049.53B

	销售	更改		日
Akebia Therapeutics	USD 57.62M		1.14M	2025-12
Alaunos Therapeutics	USD 2K		2K	2025-03
Avita Medical	AUD 17.61M		805K	2025-12
Celltrion	KRW 1.15T		180B	2026-03
Dianthus Therapeutics	USD 284K		112K	2025-12
Ionis Pharmaceuticals	USD 246M		43M	2026-03
IQVIA Holdings	USD 4.15B		210M	2026-03
Moderna	USD 389M		289M	2026-03
Organon & Co	USD 1.46B		50M	2026-03
Revvity	USD 711M		61.06M	2026-03
Tectonic Therapeutic	USD 0		0	2024-12
Viatris	USD 3.52B		180M	2026-03
Xeris Pharmaceuticals	USD 83.13M		2.68M	2026-03